Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma
about
POT1 and TRF2 cooperate to maintain telomeric integrityTIN2-tethered TPP1 recruits human telomerase to telomeres in vivoGene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomachTelomeres and human disease: ageing, cancer and beyondGenetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility.Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.Genetic modification of the relationship between phosphorylated tau and neurodegeneration.Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival.The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.A small molecule inhibitor of Pot1 binding to telomeric DNA.Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancerGene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomasTelomere-binding protein TPP1 modulates telomere homeostasis and confers radioresistance to human colorectal cancer cells.MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression.TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer.Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer.Serum concentration and expression of Reg IV in patients with esophageal cancer: Age-related elevation of serum Reg IV concentration.Telomerase: a potential therapeutic target for cancer.Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression.Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.cDNA-microarray analysis as a new tool to predict lymph node metastasis in gastric cancer.Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.The regulation of telomerase in oncogenesis.Overexpression of the Transmembrane Protein IQGAP3 Is Associated with Poor Survival of Patients with Gastric Cancer.Expression of Telomere Binding Proteins (RAP1 and POT1) in Renal Cell Carcinoma and Their Correlation with Clinicopathological Parameters.Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer.DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer.
P2860
Q24338505-71D7E79A-DAAD-4DB8-A9B0-B659BA7F94AEQ24606587-5A59C7D7-DE71-4F65-B43A-9547B3C02851Q28265236-F347CFD4-5C5A-4EED-A2A2-7C605A90F8C5Q29615353-236DF940-A562-4D3A-9849-A849E6DE0500Q33418117-BE1D0057-077A-4582-9848-AACF4A54CAD6Q33756029-FFD5EC74-9186-4E17-B7EC-FDAEB673E9AEQ33915396-F716F5D8-DE9A-4F4F-A7AB-97F872D6E6A7Q33995454-2BFA6DE5-6C4B-4975-A702-3C7346D60792Q34094684-2DCAD58B-818B-46C1-87F3-75302A80AA24Q34216985-37B8769A-CC5A-4DDA-A941-541AE555C87FQ34242914-0CFD9A1F-B2F3-48F2-877F-CECD8E1111AAQ34403242-3224C308-0449-40C2-9BCE-B0072ED4B62BQ34414940-D8089A2E-5F9D-4D90-8D2B-0419F888DC66Q34469547-7581179D-243D-4D17-9A6E-582A6DAA942AQ34514751-80E506AD-A1E8-4334-8F58-C129F6F67D49Q34559588-A00E8F8B-8C90-4884-AB38-B04DC5C18B94Q35049411-B7940DDB-3E7F-4478-8AC4-C419C0098825Q35051475-CD6EE4A5-85AA-43CE-84E0-E5EF6C9A319AQ35051738-0E535643-392B-44E9-AD54-E5187B7EB692Q35567175-A15717C0-6476-4080-B040-44058EAA7A28Q35724544-20779A58-AB42-4614-9005-C358C15E2DEEQ36135787-0861C5AE-1EFA-43F7-BD3E-2A23D725B1A0Q36158693-7AF323BE-048F-4DBF-B25D-0FD3D3EE2DF7Q36279625-5D7A3E12-BA41-435C-85AD-3271904D9989Q37468529-FEF91FEC-F02A-4D3C-B106-5AD035F2CA13Q38478183-801B1606-A258-4205-B3EB-F00D699779A3Q38698251-753D92B9-8393-4806-B2BB-12B7048D8DBCQ39744311-F8633661-F4BA-4A81-BAD1-395776D35CA2Q40979460-B0362E14-A08F-44ED-87BE-E8B30D88C9BAQ42152999-C5E0D1DC-E989-410D-8D1D-623F22D4BC76Q47409947-CA103E6E-A60A-4935-89EE-4E333CC50D5DQ47947812-C03FD6FB-78AA-4842-B611-900BE99F9CD5Q53541451-3A470D6D-4F75-4779-92E4-FE88DD6B5E19Q54505932-C3ACBEF0-E4B7-463B-BD48-DA0169590570Q54561697-2B2C5BBB-8A5E-4D98-9D96-85C69BA5F90F
P2860
Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression of POT1 is associat ...... re length in gastric carcinoma
@ast
Expression of POT1 is associat ...... re length in gastric carcinoma
@en
Expression of POT1 is associat ...... re length in gastric carcinoma
@nl
type
label
Expression of POT1 is associat ...... re length in gastric carcinoma
@ast
Expression of POT1 is associat ...... re length in gastric carcinoma
@en
Expression of POT1 is associat ...... re length in gastric carcinoma
@nl
prefLabel
Expression of POT1 is associat ...... re length in gastric carcinoma
@ast
Expression of POT1 is associat ...... re length in gastric carcinoma
@en
Expression of POT1 is associat ...... re length in gastric carcinoma
@nl
P2093
P1433
P1476
Expression of POT1 is associat ...... re length in gastric carcinoma
@en
P2093
Hirofumi Nakayama
Kazuhiro Yoshida
Kazuhito Naka
Naohide Oue
Tomohiro Kondo
Wataru Yasui
Yoshitsugu Mitani
P356
10.1158/0008-5472.CAN-03-1196
P407
P577
2004-01-15T00:00:00Z